• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Arena Pharmaceuticals

edit

Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial. They are headquartered in San Diego, CA.

Recent Milestones

edit

• 
  Arena Pharmaceuticals received $33M in Venture Round funding. (1/11/12)
  Posted 1/11/12 at 8:42pm via arenapharm.com
• 
  Arena Pharmaceuticals received $35.5M in Venture Round funding. (6/3/10)
  Posted 6/3/10 at 7:40pm via fiercebiotech.com
• 
  Arena Pharmaceuticals received $100M in Series A funding. (6/17/09)
  Posted 6/17/09 at 7:49am via fiercebiotech.com

Videos

Screenshots

edit

Sources

1. Arena Pharma gains $100M from Deerfield (fiercebiotech.com) [edit]
2. Arena Pharma lands $35M investor as it jockeys obesity drug Read more: Arena Pharma lands $35M investor as it jockeys obesity drug (fiercebiotech.com) [edit]
3. Arena Pharmaceuticals Announces $33 Million Financing (invest.arenapharm.com) [edit]